Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Autor: Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Weijer RJ; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven, the Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, the Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Deventer, the Netherlands., Koene HR; Department of Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal De Ruyter Hospital, Goes, the Netherlands., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1903-1913. Date of Electronic Publication: 2024 Feb 15.

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem.

Autor: Poels K; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands., Neppelenbroek SIM; Department of Psychosocial Research and Epidemiology (PSOE), Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands., Antoni ML; Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre, Leiden, Netherlands., Lutgens E; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian's University, Munich, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Seijkens TTP; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands t.t.seijkens@amsterdamumc.nl.; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, Netherlands.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).

A Multicenter Before-After Study on Reducing Unnecessary Diagnostics by Changing the Attitude of Caregivers: Protocol for the RODEO Project.

Autor: Bindraban RS; Acute Medicine Section, Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands., van Beneden MLH; Acute Medicine Section, Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands., Kramer MHH; Acute Medicine Section, Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands., van Solinge WW; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Neppelenbroek SIM; Department of Internal Medicine, North-West Hospital Group Alkmaar, Alkmaar, Netherlands., van Wijnen M; Department of Clinical Chemistry, Meander Medical Center, Amersfoort, Netherlands., Griffioen-Keijzer A; Department of Internal Medicine, Spaarne Gasthuis, Haarlem, Netherlands.; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, Netherlands., Al-Dulaimy M; Department of Internal Medicine, Zaans Medical Center, Zaandam, Netherlands., Ten Berg MJ; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Nanayakkara PWB; Acute Medicine Section, Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2018 Aug 21; Vol. 7 (8), pp. e10473. Date of Electronic Publication: 2018 Aug 21.

Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands.

Autor: Kersting S; Department of Hematology, HagaHospital, Den Haag, The Netherlands. Electronic address: S.kersting@hagaziekenhuis.nl., Neppelenbroek SIM; Department of Internal Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Visser HPJ; Department of Internal Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., van Gelder M; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweizer Hospital, Dordrecht, The Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Posthuma W; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands., van der Straaten HM; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, The Netherlands., Kater AP; Department of Hematology, Lymphoma and Myeloma Center, Academic Medical Center, Amsterdam-Zuidoost, The Netherlands.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2018 Jan; Vol. 18 (1), pp. 52-57. Date of Electronic Publication: 2017 Sep 25.